Cliq2Scan Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 220.76%
- Profit Growth 62.50%
- Ebitda 476.38%
- Net Worth -383.33%
- Total Assets 118.14%
About Cliq2Scan
Cliq2scan Private Limited (CPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 February 2021 (Four years 1 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arunachalam Dhandapani and Revathy Arunachalam serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300TN2021PTC141071
-
Company No.
141071
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Cliq2Scan?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arunachalam Dhandapani
|
Director | 01-Feb-2021 | Current |
|
Revathy Arunachalam
|
Director | 01-Feb-2021 | Current |
Financial Performance of Cliq2Scan.
Cliq2Scan Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 220.76% increase. The company also saw a substantial improvement in profitability, with a 62.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 383.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cliq2Scan?
Unlock access to Cliq2Scan's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Chennai Xpertz Dentofacial Imaging Centr E LlpArunachalam Dhandapani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cliq2Scan?
Cliq2Scan has a workforce of 0 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cliq2Scan, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cliq2Scan's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
